Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Endo-α-sialidase is an enzyme that catalyzes the hydrolysis of internal (2→8)-α-sialosyl linkages in oligosaccharide and polysaccharide substrates, particularly in polysialic acid chains[2]. Unlike exo-sialidases which remove terminal sialic acids from complex carbohydrates, endo-α-sialidases cleave linkages within sialic acid macromolecules[5]. The enzyme plays a significant role in bacterial pathogenesis, where sialidases broadly contribute to infection processes and bacterial colonization by modifying host glycoprotein and glycolipid substrates[3][4]. As a member of the sialidase enzyme family, endo-α-sialidase represents a potential therapeutic target for infections where bacterial sialidase activity facilitates disease pathogenesis, though specific drugs targeting this enzyme have not been identified in current literature.
No specific drugs targeting endo-α-sialidase are identified in the provided search results, therefore no specific mechanism of action for such drugs is available.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Endo-α-sialidase.